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The herpes simplex virus type 1 (HSV-1) capsid is a T516 icosahedral shell that forms in the nuclei of
infected cells. Capsid assembly also occurs in vitro in reaction mixtures created from insect cell extracts
containing recombinant baculovirus-expressed HSV-1 capsid proteins. During capsid formation, the major
capsid protein, VP5, and the scaffolding protein, pre-VP22a, condense to form structures that are extended into
procapsids by addition of the triplex proteins, VP19C and VP23. We investigated whether triplex proteins bind
to the major capsid-scaffold protein complexes as separate polypeptides or as preformed triplexes. Assembly
products from reactions lacking one triplex protein were immunoprecipitated and examined for the presence
of the other. The results showed that neither triplex protein bound unless both were present, suggesting that
interaction between VP19C and VP23 is required before either protein can participate in the assembly process.
Sucrose density gradient analysis was employed to determine the sedimentation coefficients of VP19C, VP23,
and VP19C-VP23 complexes. The results showed that the two proteins formed a complex with a sedimentation
coefficient of 7.2S, a value that is consistent with formation of a VP19C-VP232 heterotrimer. Furthermore, VP23
was observed to have a sedimentation coefficient of 4.9S, suggesting that this protein exists as a dimer in
solution. Deletion analysis of VP19C revealed two domains that may be required for attachment of the triplex
to major capsid-scaffold protein complexes; none of the deletions disrupted interaction of VP19C with VP23.
We propose that preformed triplexes (VP19C-VP232 heterotrimers) interact with major capsid-scaffold protein
complexes during assembly of the HSV-1 capsid.
Assembly of the HSV-1 capsid requires an internal scaffolding protein called pre-VP22a. The major capsid protein interacts with 25 amino acids in the carboxy-terminal domain of
pre-VP22a; these residues are cleaved upon release of the
scaffold (14, 16, 25, 34). Although the major capsid protein and
the scaffolding protein comprise the majority of the protein
mass of the capsid as it is assembled, capsid assembly will not
occur in the absence of the triplex proteins (6, 33, 35, 39). The
triplex proteins interact with major capsid-scaffold protein
complexes, forming arc- or dome-like structures called partial
capsids (20). The joining of additional subunits allows partial
capsids to grow into a spherical procapsid, which undergoes a
morphological transition to the mature icosahedral capsid and
is packaged with DNA. Three-dimensional reconstructions
computed from cryoelectron micrographs of the procapsid
show that it is a spherical structure that appears to be open and
porous, unlike the mature capsid, which is angular and tightly
sealed (20, 36). In the procapsid, the hexons are asymmetric
and only loosely formed, as opposed to the symmetric, highly
regular hexons in the mature capsid. In addition, the capsid
floor layer, which is smooth and continuous in the mature
capsid, is rudimentary and incomplete in the procapsid. Triplexes, which are visible at sites between capsomers in the
procapsid, appear to be the only substantial connection between adjacent capsomers when observed at a resolution of 26
Å (36).
As described above, analysis of the procapsid structure has
suggested an important role for the triplex proteins in capsid
assembly. Although the triplex proteins make up a relatively
small percentage of the total capsid protein, the triplexes appear to provide essential support for the capsid shell as it is
formed. Here we describe use of an in vitro system comprised

Assembly of progeny virions is an essential stage in the life
cycle of every virus. For double-stranded DNA viruses such as
bacteriophages (4), adenoviruses (7, 9), and herpesviruses (10,
28), capsid subunits initially form a precursor capsid that is
packaged with DNA and subsequently matures into an infectious particle. Assembly of the procapsid frequently requires
additional proteins, termed scaffolding proteins, that are not
present in the mature capsid.
The mature herpes simplex virus type 1 (HSV-1) capsid is an
icosahedral shell that is 125 nm in diameter and 15 nm thick
(26, 28, 29). Its major structural features are 162 capsomers
(150 hexons and 12 pentons) that lie on a T516 lattice. The
capsomers associate at their proximal ends to create a 3-nmthick floor layer. The capsomer protrusions project radially to
a distance of 11 nm from the floor layer, and each capsomer
has an axial channel. The major capsid protein, VP5, is the
structural subunit of both the hexons and the pentons (22, 23,
38). Hexons are found on the faces and edges of the icosahedron, while one penton is found at each of the 12 capsid
vertices. Two minor capsid proteins, VP19C and VP23, make
up trigonal nodules called triplexes (320 in all) found just
above the capsid floor layer at the local three-fold positions
between adjacent capsomers (22). Triplexes may vary somewhat in composition, but on average they are heterotrimers
containing one copy of VP19C and two copies of VP23 per
triplex. A third minor capsid protein, VP26, is located at the
outer tips of the hexons (3, 37, 40).
* Corresponding author. Mailing address: Department of Microbiology, Box 441, University of Virginia Health Sciences Center, Charlottesville, VA 22908. Phone: (804) 924-2504. Fax: (804) 982-1071.
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of insect cell extracts containing recombinant baculovirus-expressed capsid proteins to examine the role of the triplex
proteins in capsid assembly. We asked whether the triplex
proteins interact with the nascent capsid as separate polypeptides or as preformed structural units. In addition, we employed deletion analysis to identify domains required for triplex formation and for attachment of the triplex proteins to
major capsid-scaffold protein complexes. The results shed new
light on the essential role of the triplex proteins in HSV capsid
assembly.
MATERIALS AND METHODS
Cell lines. Thomsen et al. (35) described the construction of the four recombinant baculoviruses containing the HSV-1 UL18 (encoding VP23), UL19
(VP5), UL26.5 (pre-VP22a), and UL38 (VP19C) genes employed in this study.
The nonessential UL35 gene (VP26) was not included in assembly reactions.
Suspension cultures of Spodoptera frugiperda (Sf9) cells were infected with individual recombinant baculoviruses (multiplicity of infection of 5), and at 64 h
postinfection the cells were harvested, frozen, and diluted for use in the in vitro
system as previously described (20).
In vitro capsid assembly. Cell-free capsid assembly was performed by a modification of the procedure of Newcomb et al. (21). Assembly-competent reaction
mixtures contained aliquots of each of the four cell suspensions described above.
Cells were lysed by five repeated cycles of freezing and thawing, and then the
cellular debris was removed by centrifugation at 16,000 3 g for 5 mins. The
supernatant was decanted, and then EDTA (50 mM), dithiothreitol (10 mM),
and protease inhibitors (20 mM phenylmethylsulfonyl fluoride, aprotinin [20
mg/ml], 10 mM leupeptin, and trypsin inhibitor [100 mg/ml]) were added. The
extracts were incubated at 37°C for 30 min and clarified by centrifugation as
described above. Capsids or partial capsid structures were isolated by precipitation with the VP5-specific monoclonal antibody 6F10 as described previously
(20).
Construction of VP19C mutants. Deletions were made in the UL38 gene by
using pAc-UL38 (35) as a template for PCRs. Upstream oligonucleotide primers
were complementary to the noncoding strand and contained a BamHI restriction
site. Downstream oligonucleotide primers were complementary to the coding
strand and contained a KpnI restriction site. The UL38 gene was truncated by
placing primers at various increments in from the 59 or 39 end of the gene. The
pAc-373 vector was digested with BamHI and KpnI, gel purified, ligated to PCR
products that had been digested with the same enzymes, and transformed as
described previously (30). Plasmid DNA from positive clones was purified and
cotransfected to generate recombinant baculoviruses (35).
Electron microscopy. Cell pellets containing capsid assembly products were
prepared for electron microscopy by fixation in 2% glutaraldehyde, embedding in
Epon 812, and sectioning as previously described (20). All micrographs were
recorded on a JEOL 100CX transmission electron microscope operated at 80
keV.
Sucrose density gradient analysis. Sucrose gradients (5 to 20% sucrose in
phosphate-buffered saline) were prepared and equilibrated to 4°C (11). Extracts
containing single capsid proteins or combinations of capsid proteins were loaded
onto the gradients and immediately subjected to centrifugation at 115,000 3 g for
18 h at 4°C. Centrifugation was performed in a Beckman L5-50 Ultracentrifuge
by using an SW50.1 rotor at 35,000 rpm, and gradients were fractionated with a
Buchler Polystaltic Pump into 40 fractions of approximately 115 ml each (4
drops). Fractions were analyzed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and Western blotting to identify capsid proteins.
Coomassie blue-stained gels and X-ray films were digitized with a Molecular
Dynamics personal densitometer, and Imagequant software was used to quantitate the capsid proteins in each lane.
Sedimentation coefficient and molecular weight determination. The calculation of sedimentation coefficients was carried out by comparison with a protein
standard by the method of Martin and Ames (17). Residual bovine serum
albumin (BSA) from each of the cell cultures served as an internal standard for
each gradient. The position of BSA in the gradient was determined by SDSPAGE and Western blotting. Sedimentation coefficients for capsid proteins were
determined by a ratio of distance traveled by the capsid protein to distance
traveled by BSA. Molecular weights were approximated from the sedimentation
coefficients as described previously (17).
SDS-PAGE and Western immunoblotting. Gels were prepared with a 4%
stacking gel and a 12.5% resolving gel as described previously (22). Gels were
either stained with Coomassie blue or electrophoretically transferred to a nitrocellulose membrane for Western immunoblotting (30). Immunoblots were
stained either with polyclonal antisera specific for VP19C and/or VP23 or with a
pool of monoclonal antibodies (3N-5, 3C-16, 2-11, and 1N-11) specific for BSA.
HSV-1 B capsids, used as a standard for gel electrophoresis and immunoblotting,
were prepared as previously described from BHK-21 cells infected with the
17MP strain of HSV-1 (23).

FIG. 1. Protein compositions of products formed in the in vitro assembly
system. Cell extracts containing recombinant VP5, pre-VP22a, VP23, and VP19C
(ALL) were combined and assembly products were precipitated with the VP5specific monoclonal antibody 6F10. The precipitate was analyzed by SDS-PAGE,
and the gel was stained with Coomassie blue (a). In some reactions individual
capsid proteins were omitted. Lane 1 contains HSV-1 capsids isolated from
infected BHK cells as a protein standard, and lane 2 contains a reaction mixture
with all four recombinant proteins. Control HSV-1 capsids from infected cells
contain processed scaffolding protein (VP22a), while in vitro assembly reactions
contain uncleaved scaffolding protein (pre-VP22a). Lane 3 contains ALL minus
VP23, lane 4 contains ALL minus VP19C, and lane 5 contains ALL minus VP23
and VP19C. Two identical gels were blotted and probed with polyclonal antiserum specific for VP19C (b) or VP23 (c). One additional band is visible just
below VP19C (panel c, lane 2); this band likely represents a breakdown product
resulting from protease activity in the insect cell extract.

RESULTS
In vitro assembly reactions were performed to determine
whether the triplex proteins can associate with the nascent
capsid independently of each other or whether the capsid assembly requires the presence of preformed triplexes. Previous
studies have shown that VP5 associates with pre-VP22a in the
absence of triplex proteins to form distinct structures (16). The
structures are spherical, but they vary slightly in size, averaging
60 nm in diameter. These major capsid-scaffold protein complexes can be precipitated with the VP5-specific monoclonal
antibody 6F10 (13). Therefore, even in the absence of capsid
formation, it is possible to determine whether triplex proteins
have associated with the major capsid-scaffold protein complex
by examining the immunoprecipitate. Figure 1 shows SDSPAGE and Western immunoblot analysis of assembly reaction
mixtures consisting of cell extracts containing HSV-1 capsid
proteins.
Control reaction mixtures contained all four baculovirusexpressed capsid proteins (VP5, pre-VP22a, VP19C, and
VP23) and yielded capsids, as viewed by electron microscopy
(data not shown). SDS-PAGE analysis revealed that all four
capsid proteins were present in the precipitate (Fig. 1, lane 2).
Western blot analysis was used to show specifically whether
triplex proteins were present in each precipitate (Fig. 1b and
c). VP19C, which has a molecular weight of 50,000, migrates to
approximately the same position as the antibody heavy chain
on the SDS gel, and thus the presence of VP19C could be
detected only by immunoblotting (Fig. 1b, lane 2). A band
appearing just below the antibody heavy-chain band (Fig. 1a,
lanes 2 to 5) does not correspond to VP19C, as shown by the
immunoblotting results (Fig. 1b), and probably represents a
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contaminating cellular protein. In in vitro assembly reactions,
VP19C was observed to be very sensitive to proteolysis by
enzymes in the cell extract, and even in the presence of protease inhibitors a breakdown product, slightly smaller than the
full-length protein, is visible (Fig. 1b, lane 2). In the reaction in
which VP23 was omitted, only trace amounts of VP19C were
detected in the precipitate (Fig. 1b, lane 3). When VP19C was
omitted from the reaction mixture, VP23 was not detected in
the pellet (Fig. 1c, lane 4). Omission of both triplex proteins
(lane 5) yielded a result that appeared to be identical to that
observed when one protein or the other was omitted, suggesting that the triplex proteins are unable to bind to the major
capsid-scaffold protein complex independently of each other.
Formation of triplexes in the absence of other capsid proteins. The possibility that triplex proteins would associate in
the absence of other capsid proteins was tested by sucrose
density gradient analysis. Insect cells expressing recombinant
HSV proteins were lysed and clarified to obtain cell extracts
containing VP19C and VP23. The cell extracts were combined
and layered on top of 5 to 20% sucrose gradients prepared in
phosphate-buffered saline. Cell extracts containing each protein individually were also layered onto separate gradients, and
residual BSA from each cell culture served as an internal
standard to ensure that differences in protein migration were
not due to differences in gradient composition. Gradients were
centrifuged at 115,000 3 g for 18 h at 4°C. Forty fractions of
115 ml each (4 drops) were collected for each gradient. The
fractions were analyzed by SDS-PAGE and Western blotting,
and densitometry was used to determine the relative protein
intensity for each fraction. Optical density values were normalized for each gradient and plotted versus distance from the
meniscus in the gradient, as shown in Fig. 2.
In each gradient the BSA standard peaked in fraction 24, a
fraction corresponding to a migration of 1.9 cm from the gradient meniscus. VP19C peaked in fraction 27 at 1.5 cm from
the meniscus, while VP23 was found in fraction 23 (2.0 cm),
sedimenting slightly faster than the BSA. A major shift in
migration pattern was seen when the two triplex proteins were
combined on the gradient. Both VP19C and VP23 peaked in
fraction 15, at a distance of 2.9 cm from the meniscus. The
proteins migrated together on the gradient, with the more
rapid sedimentation indicating that a larger multiprotein complex had been formed.
The approximate size of the VP19C-VP23 complex observed
on the sucrose gradient was determined by comparison with
the BSA standard in each gradient. The sedimentation coefficient for each protein or protein complex was calculated (Table 1). The sedimentation coefficient is indirectly proportional
to the molecular weight of a protein, because factors such as
shape and arrangement of the molecule affect the friction
coefficient and thus the sedimentation. However, the approximate molecular weight for each species identified on the sucrose gradients was also calculated (Table 1). For VP19C, such
calculations yield a molecular weight of 48,000, a value that is
within 5% of the actual molecular weight of 50,260 predicted
from the DNA sequence (19). For VP23, both the sedimentation coefficient and the estimated molecular weight of 72,000
were surprising in view of the molecular weight of 34,268
predicted from the DNA sequence (19). However, given the
observation that triplexes are heterotrimers composed of one
VP19C monomer and one VP23 dimer, we suggest that VP23
may exist as a dimer in solution.
The sedimentation coefficient for the VP19C-VP23 multiprotein complex was computed to be 7.2S, with an estimated
molecular weight of 129,000. The theoretical molecular weight
for a heterotrimeric complex composed of one VP19C mono-
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FIG. 2. Sedimentation analysis of triplex proteins and protein complexes.
Cell extracts containing VP19C, VP23, or VP19C and VP23 were placed on top
of 5 to 20% sucrose gradients and centrifuged for 18 h at 115,000 3 g. Each
gradient was fractionated, and the fractions were analyzed by SDS-PAGE and
Western blotting. Protein intensity was determined with Imagequant; the values
were normalized, and the relative intensity values were plotted against distance
from the meniscus. BSA was included in each gradient as a standard. ——,
VP19C; — . — . , VP23; . . . . . ., BSA.

mer and one VP23 dimer is 118,796. These results support the
notion that VP19C and VP23 form triplexes in the absence of
other capsid proteins.
Deletion analysis of VP19C. Subsequent experiments were
designed to identify protein-protein interactions required for
capsid assembly. The VP19C protein was truncated from either
the N terminus or the C terminus by using PCR to generate
shortened versions of the UL38 coding sequence. Amino acids
were removed in increments of 45, 90, and 105 from the N
terminus, as shown by the schematic illustration in Fig. 3a. The
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TABLE 1. Physical properties of triplexes and triplex proteins
Protein

Distance from
meniscus (cm)

S

Experimentally
determined
mol wt

Actual mol wt
from DNA
sequence

BSAa
VP19C
VP23
VP19C-VP23

1.9
1.5
2.0
2.9

4.7
3.7
4.9
7.2

68,000
48,000
72,000
129,000

68,000
50,260
34,268
118,796b

a
BSA was used as a standard to calculate values for other proteins by using the
Martin and Ames equation (17).
b
Molecular weight was calculated for a VP19C-VP232 heterotrimer.

C terminus was shortened by 15 amino acids. Truncated proteins were expressed by using the recombinant baculovirus
system, and the expression of each deletion mutant was verified by Western blotting with polyclonal antiserum specific for
VP19C (Fig. 3b). Extracts containing these proteins were then
substituted for extracts containing full-length VP19C in the
assembly reactions described previously. The reaction mixtures
contained VP5, pre-VP22a, VP23, and one of the VP19C deletion mutants. Products of assembly reactions were precipitated with the VP5-specific monoclonal antibody 6F10, and the
immunoprecipitate was analyzed by Western blotting to detect
the presence of VP19C mutants (Fig. 3c). Deletion of the
N-terminal 45 amino acids did not affect the ability of the
VP19C protein to associate with the major capsid-scaffold protein complex (Fig. 3b, lane 3). The nd90 protein was present in
the precipitate; however, the amount of this protein relative to
the full-length and nd45 proteins was significantly decreased
(Fig. 3b, lane 4). The nd105 protein did not precipitate with the

FIG. 3. Schematic diagram illustrating the deletions made in the VP19C
protein (a) and Western blot detection of VP19C deletion mutants from insect
cell extracts (b) or immunoprecipitated assembly complexes (c). VP19C deletion
mutants were constructed by cloning truncated genes into baculovirus vectors as
described in the text. Proteins that contained deletions at the N terminus or C
terminus were expressed in Sf9 cells. Whole-cell lysates were analyzed by SDSPAGE followed by Western blotting with polyclonal antiserum specific for
VP19C (b). Mutants were tested in assembly reactions that included VP5, preVP22a, VP23, and either full-length VP19C or one of the deletion mutants.
Assembly products were precipitated with monoclonal antibody 6F10 and analyzed by Western blotting as described above (c).

3947

VP5-VP22a complexes, indicating that a loss of 105 amino
acids from the N terminus was too great to support interaction
with the assembly complex. In addition, the cd15 protein failed
to precipitate (Fig. 3b, lane 6), suggesting that deletion of just
15 amino acids from the C terminus prevents interaction of
VP19C with the major capsid-scaffold protein complex.
Capsids that incorporated the VP19C deletion mutants were
examined by electron microscopy. Insect cells were multiply
infected with recombinant baculoviruses expressing each of the
capsid proteins (VP5, pre-VP22a, and VP23) and one of the
VP19C deletion mutants. At 60 h postinfection the cells were
pelleted and thin sectioned to observe capsids or aberrant
assembly products. Electron micrographs of cells containing
wild-type VP19C (Fig. 4a) showed numerous capsids. The capsids were round and had a measured diameter of approximately 100 nm. An inner core, presumed to be scaffolding
protein, was visible in each capsid. Capsids of approximately
the same size and shape were also seen in cells containing nd45
and nd90 (Fig. 4b and c), although the number of capsids per
field appeared to decrease slightly as the size of the deletion
increased. In reactions containing nd90, a number of aberrant
structures resembling spirals were also seen, suggesting that
assembly with this mutant is much less efficient than with the
full-length protein. Aberrant capsids are believed to result
from assembly attempts in which the appropriate shell curvature is not maintained. No capsids or aberrant structures were
seen in sections of cells containing nd105 or cd15. This was
expected based on the observation that these proteins were not
detected in immunoprecipitated assembly complexes. Together these results demonstrate that mutants nd105 and cd15
lack the domains required for capsid assembly.
Deletions in the VP19C protein that inhibited capsid assembly could be due to the absence of sequences required for
triplex formation or to the lack of sequences involved in attachment of the triplex to the major capsid-scaffold protein
complex. To examine whether mutants that failed to support
capsid assembly were capable of interacting with VP23, extracts containing either the nd105 or cd15 protein were combined with VP23 and layered onto sucrose gradients, as previously described. The gradients were fractionated and examined
by SDS-PAGE and Western blot analysis. Densitometry was
performed to determine the concentration of capsid protein in
each fraction. The optical density for each protein was plotted
against sedimentation distance (distance [centimeters] from
the meniscus) to observe migration through the gradient, as
shown in Fig. 5. For cell extracts containing only cd15, the
protein was observed to sediment slowly, being found 1.5 cm
from the meniscus (Fig. 5a). However, when cell extracts contained cd15 combined with VP23, the sedimentation pattern
shifted. cd15 and VP23 sedimented together, peaking 3.0 cm
from the meniscus, suggesting that a larger protein complex
had formed (Fig. 5c). A similar result was observed with the
nd105 mutant. For cell extracts containing nd105, the truncated protein was observed to peak 1.4 cm from the meniscus
(Fig. 5b). When cell extracts contained nd105 combined with
VP23, both proteins were observed to peak 2.5 cm from the
meniscus (Fig. 5d). The shifts in sedimentation observed when
either mutant was combined with VP23 indicate that both
truncated proteins still contained the domains necessary for
interaction with VP23. Molecular weight computations confirmed that the observed sedimentation pattern for these protein complexes was consistent with a heterotrimeric triplex
containing one copy of the truncated VP19C and one VP23
dimer (Table 2). The predicted molecular weight for a cd15VP232 heterotrimer was 117,176, and the value for the protein
complex derived from gradient analysis was 126,000. The
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mutants are summarized in Table 3, with abilities to support
capsid assembly and triplex formation indicated. While a substantial portion of the N terminus can be deleted before effects
on capsid assembly are observed, a deletion of only 15 amino
acids from the C terminus prevents any capsid assembly. The
results suggest that two regions of VP19C, amino acids 90 to
105 and 450 to 465 (the C terminus), are required for capsid
assembly, although it has not been determined whether they
participate in direct interactions or influence other regions that
are involved. All of the truncated forms of VP19C examined in
this study were able to interact with VP23, demonstrating that
the region of VP19C that interacts with VP23 is likely to be
located between residues 105 and 450. Finally, the C terminus
of VP19C appears to specifically influence attachment of the
triplex to the major capsid-scaffold protein complexes during
capsid assembly.
DISCUSSION

FIG. 4. Electron micrographs of capsids formed by coinfection of Sf9 cells
with recombinant baculoviruses expressing VP5, pre-VP22a, VP23, and either
wild-type VP19C or one of the deletion mutants. Cell pellets were fixed and thin
sectioned. Capsids (arrows) were observed only in coinfections containing wildtype VP19 (a), nd45 (b), or nd90 (c). Aberrant structures (double arrows) were
also seen in infections containing nd90 (c). Bar, 250 nm.

nd105-VP232 complex, predicted to have a molecular weight of
107,456, had a calculated molecular weight of 96,000. Because
both proteins were observed to form complexes with VP23, this
would suggest that capsids are unable to form in reaction
mixtures containing either mutant because the triplexes lack an
element required for attachment to the major capsid-scaffold
protein complex. Properties of each of the VP19C deletion

HSV-1 capsid assembly is a complex process in which many
proteins are organized into a highly structured shell that
houses and protects the viral genome. We have employed a
cell-free system to demonstrate that protein interactions required for capsid assembly occur in a specific sequence. Our
studies show that assembly products from reaction mixtures
containing the major capsid protein, scaffold protein, and one
of the two triplex proteins consist only of major capsid and
scaffold protein. The triplex proteins, VP19C and VP23, are
unable to associate with major capsid-scaffold protein complexes independently of one another, suggesting that VP19C
and VP23 must interact with each other prior to binding to
major capsid-scaffold protein subunits for capsid assembly.
This indicates that the protein interactions are ordered such
that the major capsid and scaffolding proteins first interact to
form small subunits, as shown in Fig. 6. Heterotrimeric triplexes probably bind to these subunits, connecting them to
form arc-shaped or dome-shaped partial capsids. The addition
of more subunits results in formation of first a partial capsid
and later a spherical procapsid, which is subsequently transformed into the mature icosahedral shell (20). While this proposed pathway is derived from observations in an in vitro
system, it seems unlikely that the in vivo pathway would be
unrelated.
In addition, immunofluorescence studies have shown that in
transfected BHK cells expressing HSV capsid proteins, VP5 is
transported to the nucleus through interaction with the scaffolding protein pre-VP22a (24). Another study demonstrated
that VP23 is transported to the nucleus by VP19C (27), suggesting that such pairwise interactions may be required for all
of the assembly components to translocate to the nucleus,
where capsid assembly occurs. Studies using the two-hybrid
system failed to detect direct interactions between either triplex protein and VP5 or pre-VP22a (5), further supporting the
model that the triplex as a unit, rather than individual polypeptides, binds to VP5 and pre-VP22a.
Physical properties of the triplexes. Although interaction
between the triplex proteins, VP19C and VP23, has previously
been demonstrated by immunofluorescence (27) and in the
two-hybrid system (5), sucrose density gradient analysis was
useful for the physical characterization of the triplex. Gradient
analysis showed that both proteins had an increased sedimentation coefficient when incubated together compared to the
sedimentation coefficient for each protein when incubated
alone. Therefore, VP19C and VP23 must come together to
form a larger, more rapidly sedimenting protein complex.
While immunoprecipitation might have been an easier method
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FIG. 5. Sedimentation analysis of VP19C deletion mutants and complexes
containing mutant proteins. Cell extracts containing mutant cd15 (a), nd105 (b),
cd15 and VP23 (c), or nd105 and VP23 (d) were placed on top of 5 to 20%
sucrose gradients and centrifuged for 18 h at 115,000 3 g. Each gradient was
fractionated and analyzed as described previously, with protein intensity plotted
versus distance from the meniscus to show the location of protein peaks. BSA
was included in each gradient as a standard. ——, cd15; — . — . , nd105; . . . . . .,
BSA.

for detecting an interaction between the two proteins and
determining stoichiometry, precipitating antibodies are not
available for either VP23 or VP19C. However, molecular
weight estimations based on the sedimentation coefficient are
consistent with a heterotrimer composed of one VP19C monomer and one VP23 dimer (the expected molecular weight was
118,796; the observed molecular weight was 129,000). The protein peaks observed were not consistent with a complex composed of one VP19C monomer and one VP23 monomer, which
would be predicted to have a molecular weight of 84,528, nor
were the derived values consistent with a complex composed of
two homodimers (expected molecular weight of 169,056). A
complex containing one VP19C dimer and one VP23 monomer would have a molecular weight of 134,788, a value that is
close to the calculated molecular weight of 129,000 in this
experiment. However, considering the copy number for each
protein, as determined by scanning transmission electron microscopy (375 for VP19C and 572 for VP23), this arrangement
is unlikely to account for the majority of the triplexes (22). In
addition, gradients containing only VP23 indicated that this
protein exists as a dimer in solution, which supports the model
TABLE 2. Physical properties of truncated triplex proteins and
protein complexes
Protein

Distance from
meniscus (cm)

S

Experimentally
determined
mol wt

Actual mol wt
from DNA
sequence

BSAa
cd15
nd105
cd15-VP23
nd105-VP23

2.0
1.5
1.4
3.0
2.5

4.7
3.5
3.3
7.1
5.9

68,000
44,000
40,000
126,000
96,000

68,000
48,640
38,920
117,176b
107,456b

a

BSA was used as a standard to determine other values as described in the
text.
b
Molecular weight was calculated for a heterotrimer (VP19C mutant-VP232).
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of the triplex as a heterotrimer. Finally, recent studies of human cytomegalovirus triplex proteins mCP (minor capsid protein) and mC-BP (mCP-binding protein) have shown that
these proteins form an mCP-BP-mCP2 heterotrimer and that
mCP (VP23 homolog) exists as a dimer when expressed alone
(2). These results are consistent with our observations for
HSV-1 triplex proteins.
Preliminary evidence suggests that the complexes formed by
incubation of cell extracts containing VP19C and VP23 may be
competent for capsid assembly. Further studies are required to
determine the kinetics of each reaction; however, these studies
are complicated by the additional cellular proteins present in
the in vitro capsid assembly system. Efforts are currently being
directed at purification of each protein for equilibrium studies.
Protein interactions. Deletion of 15 amino acids from the C
terminus of VP19C resulted in a protein that was inactive in
capsid assembly. Gradient analysis, however, showed that the
truncated protein was still capable of interacting with VP23.
Based on this result, it seems likely that the sequence at the C
terminus of VP19C (451-LEGVVWRPGGWRACA-465) may
be involved in specific interactions required for attachment of
the triplex to the major capsid-scaffold protein complex. On
the basis of the 1979 report by Zweig et al. (42) of a disulfide
linkage between VP19C and VP5, it was hypothesized that the
C-terminal cysteine residue might participate in a disulfide
bond that links the triplex to the major capsid-scaffold protein
complex. However, a single amino acid substitution changing
the cysteine to an alanine (C464A) did not inhibit capsid assembly (31), suggesting that another element of the sequence
may be important.
At the N terminus of VP19C, 90 amino acids can be removed without interfering with capsid assembly, suggesting
that this domain is not involved in essential interactions. However, deletion of 105 amino acids from the N terminus did
prevent capsid assembly, possibly indicating that residues 90 to
105 either participate in protein interactions or affect other
residues that do. While there are no cysteine residues in the
N-terminal domain of the protein, residues in this region may
mediate hydrophobic interactions between capsid proteins.
Electron micrographs showed a number of aberrant structures
in cells expressing the nd90 mutant of VP19C. These structures
appear as spirals and probably result from partial capsids that
failed to maintain the proper curvature for formation of a
closed icosahedral shell. Aberrant capsids may be due to the
loss of elements required for hydrophobic interactions that
force the subunits into a T516 lattice.
Deletion analysis of VP23. In this study deletion analysis was
performed only on the VP19C triplex protein. A similar analysis performed on VP23 demonstrated that the loss of 10
residues from the C terminus or 77 amino acids from the N
terminus of VP23 inhibited capsid assembly in insect cells
infected with recombinant baculoviruses expressing each of the

TABLE 3. VP19C deletion mutant summary
Protein

Capsid assemblya

Triplex formationb

Wild-type VP19C
nd45
nd90
nd105
cd15

1
1
1
2
2

1
1
1
1
1

a
Capsid assembly was determined by immunoblot analysis of immunoprecipitated in vitro assembly reactions and by electron microscopy of in vivo reactions.
b
Triplex formation was measured by sedimentation on sucrose gradients as
described in the text.
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FIG. 6. Proposed sequence of events in the HSV-1 capsid assembly pathway, based on intermediates observed in the in vitro assembly system. The major capsid
protein and the scaffold protein interact in the cytoplasm, forming VP5–pre-VP22a complexes that are localized to the nucleus (16). VP19C and VP23 interact to form
triplexes, which then move to the nucleus. Assembly occurs by interaction of the two types of protein complexes, forming arc-like partial capsids that grow into a
procapsid shell. Finally, the spherical procapsid matures by transformation into the icosahedral capsid. In vivo, this transformation would be expected to be
accompanied by packaging of viral DNA.

capsid proteins (12). In addition, sites of interaction with
VP19C were mapped by using the two-hybrid system. These
studies showed that deletion of the N-terminal 77 residues of
VP23 prevents interaction with VP19C. Similarly, the loss of 71
residues from the C terminus also inhibited the interaction
between the two proteins, although deletion of just 10 Cterminal residues did not. Because the two-hybrid system detects single protein interactions, it is not clear whether deletions that disrupted interaction with VP19C were due to the
loss of sequences that mediate binding to VP19C or the loss of
sequences that mediate the dimerization of VP23, which may
be essential in order for interaction with VP19C to occur.
Self-association of VP23 has not been observed in the twohybrid system (5, 12), indicating that there are limitations to
this method, particularly for the analysis of structural proteins.
Triplex structure in the capsid. In high-resolution studies of
the capsid shell, Zhou et al. (41) observed that triplex structure
was influenced by the local environment. Six distinct types of
triplex based on the type of surrounding capsomers were described. Of particular interest are the triplexes located at the
threefold axes of symmetry of each triangular face, between
three central hexons. Due to symmetry imposed during reconstruction methods, the structures of these triplexes are in question. While it is interesting to speculate that a homotrimer,
rather than a heterotrimer, would likely occupy these sites, no
evidence for structures with that stoichiometry was observed
during gradient analysis in the experiments reported here.
As higher-resolution images of the HSV-1 capsid and procapsid continue to emerge, it has become clear that the triplexes may perform a role which is different from that of the
soc protein of bacteriophage T4, to which the triplexes had
been considered analogous. The soc protein is dispensable for
phage head formation and binds only to expanded, mature
phage heads (1, 15, 32). Given their essential role in maintaining procapsid structure, the HSV-1 triplex proteins seem more
comparable to the external scaffolding proteins of bacteriophages such as P4 or fX174. These proteins form cage-like
structures around the outside of the phage prohead to maintain its shape and size as it is assembled (8, 17). It has been
proposed that the external scaffolding protein Sid controls the

incorporation of hexamers into the growing P4 shell (17). We
suggest the triplexes may play a similar role in clamping VP5
subunits into the appropriate configuration for maintenance of
the icosahedron. One difference between HSV-1 triplex proteins and the external scaffolding proteins of P4 and fX174 is
that Sid and gpD are not present in the mature phage heads.
However, the triplex proteins of HSV-1, while present in the
mature capsid, do not appear to be as important in the mature
capsid as they are in the procapsid (36, 40, 41). Treatment of
the HSV-1 capsid with 2.0 M guanidine hydrochloride has
been observed to result in the loss of pentons and surrounding
triplexes without compromising capsid structure (23).
The in vitro capsid assembly system has been extensively
employed for the identification of intermediates in the HSV-1
capsid assembly pathway. As the pathway has now been delineated in some detail, the next challenge will be to use this
information for the development of therapeutics that prevent
assembly of replicating virions. In particular, blocking the transition from procapsid to capsid seems like a feasible target for
antiviral agents.
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